Becton Dickinson & Co. header image

Becton Dickinson & Co.

BDX

Equity

ISIN null / Valor 912061

New York Stock Exchange, Inc (2026-11-06)
USD 211.88-0.78%

Becton Dickinson & Co.
UMushroom community rating:

star star star star star
0.00 0 votes No rating yet
NegativeNeutralPositive

About company

Becton Dickinson & Co. (BD) is a long-established, publicly traded medical technology company headquartered in Franklin Lakes, New Jersey, that designs, manufactures and sells a broad range of medical devices, instrument systems and diagnostic products for healthcare institutions, clinical laboratories, life sciences researchers and pharmaceutical manufacturers. Its offerings include needles and syringes, infusion and medication-delivery systems, catheter and vascular access devices, prefillable drug-delivery systems and related pharmaceutical manufacturing services, as well as diagnostic instruments, specimen collection and preanalytical systems and reagents used in clinical and molecular diagnostics. BD operates globally across multiple business units that serve hospitals, outpatient facilities, labs and biopharma customers, combining product sales with service and technical support for clinical and research workflows.

Summarized from source with an LLMView SourceSector: Healthcare

Latest Results ():

Summarized from source with an LLMView Source

Key figures

19.4%1Y
-18.2%3Y
-13.1%5Y

Performance

31.7%1Y
28.2%3Y
25.7%5Y

Volatility

Market cap

57713 M

Market cap (USD)

Daily traded volume (Shares)

2,172,612

Daily traded volume (Shares)

1 day high/low

227.8 / 225.05

1 day high/low (USD)

52 weeks high/low

0.00 / 0.00

52 weeks high/low (USD)

Dividend ex-date

01 January, 2022

Dividend ex-date

Dividend

0.00

Dividend (USD)

Dividend yield (p.a.)

0.00%

Dividend yield (p.a.)

0.002022
0.002023
0.002024

Est dividend (USD)

0.00%2022
0.00%2023
0.00%2024

Est dividend yield

P/E ratio

10.00

P/E ratio

00.002022
00.002023
00.002024

Est P/E ratio

EPS

0.00

EPS (USD)

0.002022
0.002023
0.002024

Est EPS (USD)

Ratings & reviews

star star star star star

0.00

0 votes
Performance:
starstarstarstarstar
0.00
Innovation:
starstarstarstarstar
0.00
Society:
starstarstarstarstar
0.00
Nature:
starstarstarstarstar
0.00

EQUITIES OF THE SAME SECTOR

Glenmark Pharmaceuticals Limited
Glenmark Pharmaceuticals Limited Glenmark Pharmaceuticals Limited Valor: 3195888
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
4.32%INR 2,592.85
Alkem Laboratories Ltd.
Alkem Laboratories Ltd. Alkem Laboratories Ltd. Valor: 30689895
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
1.61%INR 5,265.20
Merck KGaA
Merck KGaA Merck KGaA Valor: 412799
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-1.06%EUR 148.75
Helen of Troy Ltd
Helen of Troy Ltd Helen of Troy Ltd Valor: 938381
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.90%USD 37.43
Draegerwerk AG & Co. KGaA
Draegerwerk AG & Co. KGaA Draegerwerk AG & Co. KGaA Valor: 330445
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.26%EUR 77.40
Pfizer Inc
Pfizer Inc Pfizer Inc Valor: 962004
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.93%USD 29.12
Metropolis Healthcare Ltd.
Metropolis Healthcare Ltd. Metropolis Healthcare Ltd. Valor: 11536062
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.36%INR 569.25
Basilea Pharmaceutica Ltd, Allschwil
Basilea Pharmaceutica Ltd, Allschwil Basilea Pharmaceutica Ltd, Allschwil Valor: 1143244
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.56%CHF 71.00
Newron Pharmaceuticals S.p.A.
Newron Pharmaceuticals S.p.A. Newron Pharmaceuticals S.p.A. Valor: 2791431
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.91%CHF 8.83
Demant A/S
Demant A/S Demant A/S Valor: 32651962
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.05%DKK 377.20